|
Name |
4-Epi-seco-shornephine a carboxylic acid
|
| Molecular Formula | C25H28N2O6 | |
| IUPAC Name* |
(2R)-3-[(3R)-7-hydroxy-3-(2-methylbut-3-en-2-yl)-2-oxo-1H-indol-3-yl]-2-[[(2S)-2-hydroxy-3-phenylpropanoyl]amino]propanoic acid
|
|
| SMILES |
CC(C)(C=C)[C@@]1(C2=C(C(=CC=C2)O)NC1=O)C[C@H](C(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)O
|
|
| InChI |
InChI=1S/C25H28N2O6/c1-4-24(2,3)25(16-11-8-12-18(28)20(16)27-23(25)33)14-17(22(31)32)26-21(30)19(29)13-15-9-6-5-7-10-15/h4-12,17,19,28-29H,1,13-14H2,2-3H3,(H,26,30)(H,27,33)(H,31,32)/t17-,19+,25-/m1/s1
|
|
| InChIKey |
TXVLBRMNUYNGCT-VDABOFBKSA-N
|
|
| Synonyms |
4-epi-seco-shornephine a carboxylic acid
|
|
| CAS | NA | |
| PubChem CID | 156580567 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 452.5 | ALogp: | 2.9 |
| HBD: | 5 | HBA: | 6 |
| Rotatable Bonds: | 9 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 136.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 33 | QED Weighted: | 0.293 |
| Caco-2 Permeability: | -5.848 | MDCK Permeability: | 0.00001530 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.014 |
| Human Intestinal Absorption (HIA): | 0.214 | 20% Bioavailability (F20%): | 0.847 |
| 30% Bioavailability (F30%): | 0.008 |
| Blood-Brain-Barrier Penetration (BBB): | 0.036 | Plasma Protein Binding (PPB): | 96.86% |
| Volume Distribution (VD): | 0.163 | Fu: | 3.55% |
| CYP1A2-inhibitor: | 0.012 | CYP1A2-substrate: | 0.086 |
| CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.194 |
| CYP2C9-inhibitor: | 0.263 | CYP2C9-substrate: | 0.971 |
| CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.179 |
| CYP3A4-inhibitor: | 0.121 | CYP3A4-substrate: | 0.418 |
| Clearance (CL): | 0.575 | Half-life (T1/2): | 0.86 |
| hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.182 |
| Drug-inuced Liver Injury (DILI): | 0.736 | AMES Toxicity: | 0.024 |
| Rat Oral Acute Toxicity: | 0.819 | Maximum Recommended Daily Dose: | 0.041 |
| Skin Sensitization: | 0.038 | Carcinogencity: | 0.034 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
| Respiratory Toxicity: | 0.049 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004262 | ![]() |
0.867 | D0RA5Q | ![]() |
0.393 | ||
| ENC001985 | ![]() |
0.432 | D0D7KC | ![]() |
0.351 | ||
| ENC004235 | ![]() |
0.417 | D0A8XN | ![]() |
0.331 | ||
| ENC001904 | ![]() |
0.382 | D0L0SW | ![]() |
0.326 | ||
| ENC000717 | ![]() |
0.365 | D0SH3I | ![]() |
0.323 | ||
| ENC003221 | ![]() |
0.344 | D0BV3J | ![]() |
0.322 | ||
| ENC003246 | ![]() |
0.344 | D06PSS | ![]() |
0.316 | ||
| ENC004494 | ![]() |
0.333 | D02NEH | ![]() |
0.313 | ||
| ENC005251 | ![]() |
0.333 | D0W9WF | ![]() |
0.312 | ||
| ENC004607 | ![]() |
0.331 | D0Y0JH | ![]() |
0.312 | ||